Loading provider…
Loading provider…
Radiation Oncology Physician in Grand Forks, ND
NPI: 1427252014Primary Practice Location
ALTRU HOSPITAL
1200 S Columbia Rd, Grand Forks, ND
Primary Employer
Altru 1300 Columbia
altru.org
HQ Phone
Get M.D. Grant's Phone NumberMobile
Get M.D. Grant's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMN State Medical License
ND State Medical License
TX State Medical License
CA State Medical License
MI State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 175 | 262 |
| 2 | 77300Calculation of radiation therapy dose | 153 | 267 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 132 | 132 |
| 4 | 77014Ct scan guidance for insertion of radiation therapy fields | 128 | 2,131 |
| 5 | 77427Radiation treatment management, 5 treatment sessions | 114 | 361 |
N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.
Authors: Miran Blanchard, Robert Foote, Lisa Mcgee, Yolanda Garces, Jean-Claude Rwigema, Michelle Neben Wittich
Publication Date: 2018-08-28
Authors: Daniel Petereit, Charles Loprinzi, Rex Mowat
Journal: Int J Radiat Oncol Biol Phys
Publication Date: 2016-04-23
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Cabozantinib, PROCEDURE: Computed Tomography, PROCEDURE: Bone Scan
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Pembrolizumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, RADIATION: Radiation Therapy, OTHER: Best Practice, PROCEDURE: Computed Tomography